# Enveric Biosciences, Inc.: Form 8-K, filed Mar 4, 2020

- Company: [Enveric Biosciences, Inc.](/companies/envb.md) (CIK 890821)
- Form: 8-K
- Filed: 2020-03-04
- Accepted by EDGAR: Mar 4, 2020, 16:05 ET
- Period: 2020-02-27
- Accession: 0001140361-20-004807
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/890821/000114036120004807/form8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/890821/000114036120004807/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/890821/000114036120004807/form8k.htm

Filed Mar 4, 2020.
Source: SEC EDGAR, the filing index for accession 0001140361-20-004807. Last ingested by Listed: Nov 14, 2026, 20:02 ET. No prices; not investment advice.
